Riskpilot← Back to searchSign inGet full accessÖrebro Medkonsult AB
ABActiveOrg 5569300345Ålvägen 12General medical practice activities · NACE 8621Est. 20130 employees
Revenue 2025
SEK 355K
-68% vs 2024
EBITDA margin
80.6%
-71% vs 2024
Equity ratio
91.7%
Financial strength
Net profit 2025
SEK 246K
-69% vs 2024
| Revenue | SEK 355K | -68% |
| EBITDA | SEK 286K | -71% |
| Net profit | SEK 246K | -69% |
| Total assets | SEK 939K | -26% |
| Equity | SEK 862K | -11% |
| Employees | 0 | — |
Legal name
Örebro Medkonsult AB
Org number
5569300345
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 april 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall framställa närproducerade drycker och livsmedel samt bedriva konsultation och medicinska tjänster inom hälso- och sjukvård, värdepapper samt därmed förenlig verksamhet.
Address
Ålvägen 12
Phone
+4619121448
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 97 | 686 | 1 222 | 1 111 | 355 |
| Staff expenses | — | — | −43 | −35 | −10 |
| EBITDA | 77 | 616 | 1 058 | 974 | 286 |
| Depreciation & amort. | −0 | −3 | −6 | −6 | −6 |
| EBIT | 77 | 613 | 1 052 | 968 | 280 |
| Net financials | — | — | 2 | 21 | 28 |
| Profit before tax | 77 | 613 | 1 054 | 989 | 309 |
| Tax | −17 | −127 | −218 | −203 | −63 |
| Net profit | 60 | 486 | 836 | 785 | 246 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 234 | 866 | 1 394 | 1 266 | 939 |
| Equity | 118 | 545 | 931 | 966 | 862 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 116 | 321 | 463 | 299 | 78 |
| Total debt | 116 | 321 | 463 | 299 | 78 |
EBITDA margin
80.6%
This company
15.8%
Market median
+410% vs market
20212025
Equity ratio
91.7%
This company
38.2%
Market median
+140% vs market
20212025
Return on equity
28.5%
This company
18.4%
Market median
+55% vs market
20212025
Net profit margin
69.2%
This company
8.1%
Market median
+754% vs market
20212025
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Örebro Medkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Peter Rask | Board of Directors | 0 companies |
| Eva Maria Gisela Rask | Deputy Board Member | 0 companies |